REMINDER: REBATE RULE WOULD DO NOTHING TO LOWER DRUG PRICES WHILE HIKING PREMIUMS ON SENIORS AND COSTING TAXPAYERS $200 BILLION

11-16-2020 Blog Posts

Administration Should Abandon Misguided Policy That Rewards Drug Companies’ Price-Gouging and Anti-Competitive Tactics With Massive Bailout On Monday, the Trump Administration took a step toward enacting a misguided policy aimed at eliminating prescription drug rebates in Medicare Part D called the Rebate Rule by sending the measure to the Office of Management and Budget (OMB) […]

BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA & BRISTOL-MYERS SQUIBB

11-5-2020 Blog Posts

Big Pharma Completes Sweep of Beating Wall Street Expectations After 2020 Price Hikes In a final round of third quarter earnings reports, three more Big Pharma giants announced they surpassed earnings expectations after hiking prices on American patients. AbbVie, AstraZeneca and Bristol-Myers Squibb reported sky-high profits after hiking prices on American patients earlier this year. […]

BIG PHARMA EARNINGS WATCH: AMGEN & SANOFI

11-5-2020 Blog Posts

Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giants Amgen and Sanofi topped earnings expectations while continuing to hike prices, according to third-quarter earnings reported last week. Amgen The company beat expectations, reporting earnings per share of $4.37 for Q3, better than the estimate of $3.78. The company reported sales of […]

CSRXP: GILEAD’S PRICE-GOUGING AMERICAN PUBLIC ON COVID-19 TREATMENT TAXPAYERS PAID TO DEVELOP

10-30-2020 Blog Posts

Big Pharma Company Reaping Profit Margin Higher Than 90 Percent on Remdesivir After Setting Price More Than 13 Times Cost of Production For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday reacting to reports that Big Pharma giant Gilead is reaping profit […]

SECOND OPINION: BIG PHARMA GAMES THE PATENT SYSTEM TO HIKE PRICES AND BOOST PROFITS — NOT ‘DRIVE INNOVATION’ OR ‘ENHANCE PATIENT ACCESS’

10-29-2020 Blog Posts

Drug Companies’ Anti-Competitive Gamesmanship Comes At Tremendous Cost To U.S. Health Care System And Contributes To Out-of-Control Prescription Drug Prices Following a hearing earlier this month where lawmakers on the U.S. House Committee on Oversight and Reform blasted Big Pharma executives and exposed egregious examples of the industry’s anti-competitive tactics, the industry’s principal lobbying arm […]

BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE

10-29-2020 Blog Posts

Brand Name Big Pharma Giant Surpasses Expectations After Hiking Prices A new third quarter earnings report released today from Big Pharma giant GlaxoSmithKline (GSK) demonstrates yet again that price hikes continue to support big time profits for brand name drug companies.  The pharmaceutical manufacturer beat Wall Street expectations for the third quarter of 2020. The […]

BIG PHARMA EARNINGS WATCH: MERCK, NOVARTIS & PFIZER

10-28-2020 Blog Posts

Brand Name Drug Companies Beat Wall Street Expectations After Repeatedly Hiking Prices New earnings reports for the third quarter of 2020 show that Big Pharma giants are continuing to rake in profits while hiking prescription drug prices. On Tuesday, Big Pharma drug companies Merck, Novartis and Pfizer announced earnings for the third quarter that bested […]

ICYMI: BIG PHARMA’S PANDEMIC PRICE HIKES AND PATENT ABUSE UNDERSCORE URGENCY FOR ACTION

10-28-2020 Blog Posts

Big Pharma’s Pandemic Price Hikes and Patent Abuse Underscore Urgency for Action By Lauren Aronson Morning Consult October 28, 2020 https://morningconsult.com/opinions/big-pharmas-pandemic-price-hikes-and-patent-abuse-underscore-urgency-for-action/ Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs. Now, the economic impact of the health crisis continues to leave millions of American workers, families and seniors struggling […]

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

10-13-2020 Blog Posts

Price Hikes Fuel Q3 Earnings Beat For Brand Name Giant As millions of Americans continue to grapple with the economic impact of the COVD-19 pandemic, the first earnings report for the second quarter of 2020 from a Big Pharma giant demonstrates that hiking prices on American patients continues to be a profitable practice for the […]

SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD INCREASE OOP COSTS AND PREMIUMS FOR SENIORS — DO NOTHING TO LOWER RX PRICES

10-5-2020 Blog Posts

Big Pharma Claims Misguided Proposal Would Benefit Patients, Facts Show It Would Hand Drug Companies a More Than $100 Billion Bailout During a recent POLITICO webinar “Solving America’s Drug Pricing Puzzle,” Kristen Bernie, Deputy Vice President of Policy and Research for PhRMA, claimed the misguided Rebate Rule would benefit American patients. “I would argue that the executive […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.